Delivery Of miR-375 And Doxorubicin By Lipid-Coated Hollow Mesoporous Silica Nanoparticles To Overcome Multiple Drug Resistance In Hepatocellular Carcinoma [Corrigendum]
Xue H, Yu Z, Liu Y, et al. Int J Nanomedicine.2017;12:5271–5287. The authors of this paper have advised that Figure 8E is incorrect. Because of the similar label of groups LHD/miR-375 and LH/miR-375, the authors uploaded the wrong figure by mistake. The authors have confi...
Guardado en:
Autores principales: | , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/af63fabb28d740568236a29627b844f1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:af63fabb28d740568236a29627b844f1 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:af63fabb28d740568236a29627b844f12021-12-02T11:26:41ZDelivery Of miR-375 And Doxorubicin By Lipid-Coated Hollow Mesoporous Silica Nanoparticles To Overcome Multiple Drug Resistance In Hepatocellular Carcinoma [Corrigendum]1178-2013https://doaj.org/article/af63fabb28d740568236a29627b844f12019-11-01T00:00:00Zhttps://www.dovepress.com/httpswwwdovepresscomcorrigendum-delivery-of-mir-375-and-doxorubicin-hy-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Xue H, Yu Z, Liu Y, et al. Int J Nanomedicine.2017;12:5271–5287. The authors of this paper have advised that Figure 8E is incorrect. Because of the similar label of groups LHD/miR-375 and LH/miR-375, the authors uploaded the wrong figure by mistake. The authors have confirmed this correction will not make any change to the conclusion of their original research. Read the original articleXue HYu ZLiu YYuan WYang TYou JHe XLee RJLi LXu CDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 14, Pp 8753-8754 (2019) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine (General) R5-920 |
spellingShingle |
Medicine (General) R5-920 Xue H Yu Z Liu Y Yuan W Yang T You J He X Lee RJ Li L Xu C Delivery Of miR-375 And Doxorubicin By Lipid-Coated Hollow Mesoporous Silica Nanoparticles To Overcome Multiple Drug Resistance In Hepatocellular Carcinoma [Corrigendum] |
description |
Xue H, Yu Z, Liu Y, et al. Int J Nanomedicine.2017;12:5271–5287.
The authors of this paper have advised that Figure 8E is incorrect. Because of the similar label of groups LHD/miR-375 and LH/miR-375, the authors uploaded the wrong figure by mistake. The authors have confirmed this correction will not make any change to the conclusion of their original research.
Read the original article |
format |
article |
author |
Xue H Yu Z Liu Y Yuan W Yang T You J He X Lee RJ Li L Xu C |
author_facet |
Xue H Yu Z Liu Y Yuan W Yang T You J He X Lee RJ Li L Xu C |
author_sort |
Xue H |
title |
Delivery Of miR-375 And Doxorubicin By Lipid-Coated Hollow Mesoporous Silica Nanoparticles To Overcome Multiple Drug Resistance In Hepatocellular Carcinoma [Corrigendum] |
title_short |
Delivery Of miR-375 And Doxorubicin By Lipid-Coated Hollow Mesoporous Silica Nanoparticles To Overcome Multiple Drug Resistance In Hepatocellular Carcinoma [Corrigendum] |
title_full |
Delivery Of miR-375 And Doxorubicin By Lipid-Coated Hollow Mesoporous Silica Nanoparticles To Overcome Multiple Drug Resistance In Hepatocellular Carcinoma [Corrigendum] |
title_fullStr |
Delivery Of miR-375 And Doxorubicin By Lipid-Coated Hollow Mesoporous Silica Nanoparticles To Overcome Multiple Drug Resistance In Hepatocellular Carcinoma [Corrigendum] |
title_full_unstemmed |
Delivery Of miR-375 And Doxorubicin By Lipid-Coated Hollow Mesoporous Silica Nanoparticles To Overcome Multiple Drug Resistance In Hepatocellular Carcinoma [Corrigendum] |
title_sort |
delivery of mir-375 and doxorubicin by lipid-coated hollow mesoporous silica nanoparticles to overcome multiple drug resistance in hepatocellular carcinoma [corrigendum] |
publisher |
Dove Medical Press |
publishDate |
2019 |
url |
https://doaj.org/article/af63fabb28d740568236a29627b844f1 |
work_keys_str_mv |
AT xueh deliveryofmir375anddoxorubicinbylipidcoatedhollowmesoporoussilicananoparticlestoovercomemultipledrugresistanceinhepatocellularcarcinomacorrigendum AT yuz deliveryofmir375anddoxorubicinbylipidcoatedhollowmesoporoussilicananoparticlestoovercomemultipledrugresistanceinhepatocellularcarcinomacorrigendum AT liuy deliveryofmir375anddoxorubicinbylipidcoatedhollowmesoporoussilicananoparticlestoovercomemultipledrugresistanceinhepatocellularcarcinomacorrigendum AT yuanw deliveryofmir375anddoxorubicinbylipidcoatedhollowmesoporoussilicananoparticlestoovercomemultipledrugresistanceinhepatocellularcarcinomacorrigendum AT yangt deliveryofmir375anddoxorubicinbylipidcoatedhollowmesoporoussilicananoparticlestoovercomemultipledrugresistanceinhepatocellularcarcinomacorrigendum AT youj deliveryofmir375anddoxorubicinbylipidcoatedhollowmesoporoussilicananoparticlestoovercomemultipledrugresistanceinhepatocellularcarcinomacorrigendum AT hex deliveryofmir375anddoxorubicinbylipidcoatedhollowmesoporoussilicananoparticlestoovercomemultipledrugresistanceinhepatocellularcarcinomacorrigendum AT leerj deliveryofmir375anddoxorubicinbylipidcoatedhollowmesoporoussilicananoparticlestoovercomemultipledrugresistanceinhepatocellularcarcinomacorrigendum AT lil deliveryofmir375anddoxorubicinbylipidcoatedhollowmesoporoussilicananoparticlestoovercomemultipledrugresistanceinhepatocellularcarcinomacorrigendum AT xuc deliveryofmir375anddoxorubicinbylipidcoatedhollowmesoporoussilicananoparticlestoovercomemultipledrugresistanceinhepatocellularcarcinomacorrigendum |
_version_ |
1718395957096218624 |